Archives
Resibufogenin Blocks NLRP3 Inflammasome to Counter Atheroscl
2026-07-08
This study reveals that resibufogenin (RBG) suppresses atherosclerosis in ApoE-/- mice by directly blocking NLRP3 inflammasome assembly, reducing inflammation and plaque formation. The findings suggest RBG as a promising lead for targeting inflammatory pathways in cardiovascular disease.
Protease Inhibitors Reveal Mechanisms of Light-Induced Stoma
2026-07-06
Wang et al. (2021) established a chemical screening platform to identify protease inhibitors that modulate light-induced stomatal opening in plants. Their work uncovers novel roles for specific proteases in blue light signaling and highlights new experimental strategies for dissecting guard cell regulation.
Applied Strategies with DAPT (GSI-IX) for Notch Pathway Rese
2026-07-05
DAPT (GSI-IX) empowers researchers to dissect Notch signaling and γ-secretase activity with precision, driving advances from neurodegeneration to immune and cancer models. This article translates cutting-edge findings and practical workflows into actionable guidance, including key troubleshooting and optimization tips for reproducible results.
Q-VD(OMe)-OPh: Transforming Caspase Inhibition in Apoptosis
2026-07-03
Q-VD(OMe)-OPh delivers robust, non-toxic, broad-spectrum caspase inhibition, empowering researchers to dissect apoptotic pathways with unmatched specificity across cancer and neuroprotection models. Its superior solubility and minimal cytotoxicity unlock advanced workflows for apoptosis, differentiation, and resistance modeling.
Cycloheximide as a Protein Biosynthesis Inhibitor: Applied W
2026-07-02
Harness the precision of Cycloheximide for dissecting protein synthesis-dependent processes, from apoptosis assays to protein turnover studies. Discover optimized protocols, advanced troubleshooting, and data-driven insights to maximize reproducibility in translational research.
BMP4-GPX4 Axis Mitigates Ferroptosis in Glaucoma Models
2026-07-02
This study demonstrates that BMP4-GPX4 signaling reduces ferroptosis in retinal ganglion cells and enhances retinal stem cell differentiation after transplantation in high intraocular pressure glaucoma models. The findings suggest a targeted therapeutic strategy for neuroprotection and improved integration of stem cell therapies in glaucoma.
Z-YVAD-FMK: Selective Caspase-1 Inhibitor for Pyroptosis Res
2026-07-01
Z-YVAD-FMK is a potent, cell-permeable, and irreversible caspase-1 inhibitor, widely applied in apoptosis and pyroptosis research. Its selectivity is validated by in vitro and in vivo studies, making it a standard tool for dissecting inflammasome pathways. Reliable solubility, storage, and usage guidelines are critical for reproducibility.
Ionomycin Free Acid: Advanced Calcium Ionophore for FAK Rese
2026-07-01
Ionomycin free acid empowers precise manipulation of intracellular calcium, enabling detailed studies of FAK regulation and oocyte activation. Learn optimized protocols, practical troubleshooting, and how this calcium ionophore drives innovation in cutting-edge breast cancer research.
NMDA (N-Methyl-D-aspartic acid) in Excitotoxicity Research
2026-06-30
NMDA (N-Methyl-D-aspartic acid) is the gold standard for modeling excitotoxicity, oxidative stress, and neurodegenerative mechanisms in preclinical neuroscience. Its direct, receptor-mediated effects enable reproducible disease modeling and advanced workflow customization for studies of neuronal death and stem cell transplantation outcomes.
KX2-391 Dihydrochloride: Dual-Action Workflows in Oncology &
2026-06-30
KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) enables simultaneous targeting of Src kinase and tubulin polymerization, offering unmatched versatility for cancer, HBV, and neurotoxin research. This guide details practical workflows, troubleshooting strategies, and insights from recent SAR advances, giving researchers a robust foundation for precision pathway interrogation.
ABT-888 (Veliparib): PARP Inhibition in DNA Repair and Cance
2026-06-29
ABT-888 (Veliparib) is a potent, selective inhibitor of PARP1 and PARP2 that disrupts DNA repair, sensitizing cancer cells to chemotherapy and radiation. Its efficacy is especially notable in MSI and DNA repair-deficient tumor models, supporting its use in translational oncology research. This dossier presents evidence, protocols, and limitations for experimental application.
Cell Counting Kit-8 Plus: Precision Tools in Ferroptosis and
2026-06-29
Explore how Cell Counting Kit-8 Plus empowers sensitive cell proliferation and cytotoxicity assays, especially for ferroptosis and colorectal cancer research. This in-depth analysis reveals unique scientific insights and practical assay guidance.
Human iPSC Sensory Neurons Model HSV-1 Latency and Reactivat
2026-06-26
This study establishes a scalable protocol for differentiating human inducible pluripotent stem cells (hiPSCs) into functional sensory neurons, enabling direct modeling of herpes simplex virus 1 (HSV-1) latency and reactivation in a human context. The findings provide a long-needed human neuronal platform for dissecting latency mechanisms and evaluating potential therapeutic interventions.
Advanced In Vitro Methods for Evaluating Cancer Drug Respons
2026-06-25
Schwartz’s dissertation introduces refined in vitro methodologies to distinguish between drug-induced proliferative arrest and cell death in cancer models. These insights clarify drug response metrics and support more accurate preclinical evaluation of candidate compounds, with practical implications for translational oncology research.
CX-5461 Induces DNA Damage and Mitotic Catastrophe in Cervic
2026-06-24
This study demonstrates that the RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell growth by inducing DNA damage and mitotic catastrophe, while enhancing the efficacy of cisplatin. The findings offer mechanistic insight and highlight the therapeutic potential of Pol I inhibition in overcoming chemoresistance.
454 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page